, Volume 49, Supplement 2, pp 185–187 | Cite as

Effect of Quinolone Use on Antimicrobial Susceptibility Patterns over a 5-Year Period

  • John Segreti
  • Rita Connelly
Oraland Poster Presentations Pharmacology


Fluoroquinolone Ofloxacin Quinolone Norfloxacin Quinolone Resistance 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Neu HC. Bacterial resistance to fluoroquinolones. Rev Infect Dis 1988; 10: S57–63PubMedCrossRefGoogle Scholar
  2. 2.
    Hooper DC, Wolfson JS. Bacterial resistance to the quinolone antimicrobial agents. Am J Med 1989; 87: 17–23SGoogle Scholar
  3. 3.
    Segreti J, Gootz TD, Goodman LJ, et al. High-level quinolone resistance in clinical isolates of Campylobacter jejuni. J Infect Dis 1992; 165: 667–70PubMedCrossRefGoogle Scholar
  4. 4.
    Truckis M, Hooper DC, Wolfson JS. Emerging resistance to fluoroquinolones in staphylococci: an alert [editorial]. Ann Intern Med 1991; 114: 424–5Google Scholar
  5. 5.
    Muder RR, Brennen C, Goetz AM, et al. Association with prior fluoroquinolone therapy of widespread ciprofloxacin resistance among Gram-negative isolates in a Veterans Affairs medical center. Antimicrob Agents Chemother 1991; 35: 256–8PubMedCrossRefGoogle Scholar
  6. 6.
    Richard P, Delangle M-H, Merrien D, et al. Fluoroquinolone use and fluoroquinolone resistance: is there an association?. Clin Infect Dis 1994; 19: 54–9PubMedCrossRefGoogle Scholar
  7. 7.
    McGowan Jr JE. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 1983; 5: 1033–48PubMedCrossRefGoogle Scholar
  8. 8.
    Moody MM, de Jongh CA, Schimpff SC, et al. Long-term amikacin use: effects on aminoglycoside susceptibility patterns of Gram-negative bacilli. JAMA 1982; 248: 1199–202PubMedCrossRefGoogle Scholar
  9. 9.
    Betts RF, Valenti WM, Chapman SW, et al. Five-year surveillance of aminoglycoside usage in a university hospital. Ann Intern Med 1984; 100: 219–22PubMedGoogle Scholar
  10. 10.
    Pozdol T, Postelnick M, Peterson L, et al. Effect of changes in quinolone usage on Pseudomonas aeruginosa (PSAE) susceptibility patterns [abstract no. 234]. 33rd ICAAC, New Orleans, LA: American Society for Microbiology, 1993: 162Google Scholar
  11. 11.
    National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. 4th ed. Approved standard M2-A4. Villanova, PA: NCCLS, 1990Google Scholar
  12. 12.
    Kresken M, Wiedemann B. Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin. Antimicrob Agents Chemother 1988; 32: 1285–8PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 1995

Authors and Affiliations

  • John Segreti
    • 1
  • Rita Connelly
    • 2
  1. 1.Department of Medicine, Section of Infectious DiseaseRush-Presbyterian-St Luke’s Medical Center, Rush Medical CollegeChicagoUSA
  2. 2.Department of PharmacyRush-Presbyterian-St Luke’s Medical CenterChicagoUSA

Personalised recommendations